Lost in the Black box: Juvenile Depression, Suicide and the FDA’s Black Box
December 01, 2005 | Print > Academic Article | For Providers | Depression | Medication | Suicide and Self-Harm
Provides information regarding depression and suicide in youth and discusses the “black box warning” regarding an increased risk of suicidal ideation in depressed youth taking SSRI medications.
Reference:
Rappaport N, Prince JB, Bostic JQ. Lost in the Black box: Juvenile Depression, Suicide and the FDA’s Black Box. J of Pediatrics 2005; 47:719-720.